Simulect

Simulect

basiliximab

Manufacturer:

Novartis

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Basiliximab
Indications/Uses
Prophylaxis of acute organ rejection.
Dosage/Direction for Use
Adult & childn ≥2 yr, ≥35 kg 20 mg/dose, <35 kg 10 mg/dose. 1st dose: 2 hr prior to transplantation surgery. 2nd dose: 4 days after transplantation.
Contraindications
History of severe hypersensitivity/anaphylactoid-type reactions w/ Simulect.
Special Precautions
Breastfeeding (discontinue for 8 wk after the 2nd dose).
Adverse Reactions
Rarely, hypersensitivity/anaphylactoid-type reactions eg, rash, urticaria, sneezing, wheezing, bronchospasm, pulmonary edema, cardiac failure, resp failure & capillary leak syndrome.
Drug Interactions
Immunosuppressives other than ciclosporin & corticosteroids may increase the potential for over-immunosuppression.
MIMS Class
Immunosuppressants
ATC Classification
L04AC02 - basiliximab ; Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
Presentation/Packing
Form
Simulect powd for inj 20 mg
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in